{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:44:55Z","timestamp":1795041895590,"version":"4.10.2"},"reference-count":75,"publisher":"American Chemical Society (ACS)","issue":"21","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We herein report the conventional and microscale parallel synthesis of selective inhibitors of human blood coagulation factor XIIa and thrombin exhibiting a 1,2,4-triazol-5-amine scaffold. Structural variations of this scaffold allowed identifying derivative 21i, a potent 29 nM inhibitor of FXIIa, with improved selectivity over other tested serine proteases and also finding compound 21m with 27 nM inhibitory activity toward thrombin. For the first time, acylated 1,2,4-triazol-5-amines were proved to have anticoagulant properties and the ability to affect thrombin- and cancer-cell-induced platelet aggregation. Performed mass spectrometric analysis and molecular modeling allowed us to discover previously unknown interactions between the synthesized inhibitors and the active site of FXIIa, which uncovered the mechanistic details of FXIIa inhibition. Synthesized compounds represent a promising starting point for the development of novel antithrombotic drugs or chemical tools for studying the role of FXIIa and thrombin in physiological and pathological processes.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.0c01635","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T05:19:15Z","timestamp":1603343955000},"page":"13159-13186","source":"Crossref","is-referenced-by-count":35,"title":["Acylated 1\n                    <i>H<\/i>\n                    \u20111,2,4-Triazol-5-amines\nTargeting Human Coagulation Factor XIIa and Thrombin: Conventional\nand Microscale Synthesis, Anticoagulant Properties, and Mechanism\nof Action"],"prefix":"10.1021","volume":"63","author":[{"given":"Marvin","family":"Korff","sequence":"first","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 48 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Imberg","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 48 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas M.","family":"Will","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 30 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Bu\u0308ckrei\u00df","sequence":"additional","affiliation":[{"name":"University of Bonn , , An der Immenburg 4 , ,","place":["Bonn, Germany, 53121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7564-8213","authenticated-orcid":true,"given":"Svetlana A.","family":"Kalinina","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 45 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Wenzel","sequence":"additional","affiliation":[{"name":"Philipps University Marburg , , Marbacher Weg 6 , ,","place":["Marburg, Germany, 35032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor A.","family":"Kastner","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 48 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-3673","authenticated-orcid":true,"given":"Constantin G.","family":"Daniliuc","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 40 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Barth","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 48 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzanna A.","family":"Ovsepyan","sequence":"additional","affiliation":[{"name":"Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology , , Samory Mashela str. 1, GSP-7 , ,","place":["Moscow, Russia, 117997"]},{"name":"Russian Academy of Sciences , , 4 Kosygina St , ,","place":["Moscow, Russia, 119991"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-6953","authenticated-orcid":true,"given":"Kirill R.","family":"Butov","sequence":"additional","affiliation":[{"name":"Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology , , Samory Mashela str. 1, GSP-7 , ,","place":["Moscow, Russia, 117997"]},{"name":"Russian Academy of Sciences , , 4 Kosygina St , ,","place":["Moscow, Russia, 119991"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3296-3058","authenticated-orcid":true,"given":"Hans-Ulrich","family":"Humpf","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 45 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Lehr","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 48 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Panteleev","sequence":"additional","affiliation":[{"name":"Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology , , Samory Mashela str. 1, GSP-7 , ,","place":["Moscow, Russia, 117997"]},{"name":"Lomonosov Moscow State University , , 1\/2 Leninskie gory , ,","place":["Moscow, Russia, 119991"]},{"name":"Russian Academy of Sciences , , 4 Kosygina St , ,","place":["Moscow, Russia, 119991"]},{"name":"Moscow Institute of Physics and Technology , , 9 Institutskii per. , ,","place":["Dolgoprudnyi, Russia, 141700"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-4204","authenticated-orcid":true,"given":"Antti","family":"Poso","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , ,","place":["Kuopio, Finland, 70211"]},{"name":"University Hospital Tu\u0308bingen , , ,","place":["Tu\u0308bingen, Germany, 72076"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1774-6787","authenticated-orcid":true,"given":"Uwe","family":"Karst","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 30 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-4754","authenticated-orcid":true,"given":"Torsten","family":"Steinmetzer","sequence":"additional","affiliation":[{"name":"Philipps University Marburg , , Marbacher Weg 6 , ,","place":["Marburg, Germany, 35032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Bendas","sequence":"additional","affiliation":[{"name":"University of Bonn , , An der Immenburg 4 , ,","place":["Bonn, Germany, 53121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2717-5364","authenticated-orcid":true,"given":"Dmitrii V.","family":"Kalinin","sequence":"additional","affiliation":[{"name":"University of Mu\u0308nster , , Corrensstra\u00dfe 48 , ,","place":["Mu\u0308nster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"2026081717102365300_cit1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/B978-0-12-812615-8.00002-8","article-title":"Chapter 2 -\nPathology of Arterial Thrombosis: Characteristics and Thrombus Types","volume-title":"Cardiovascular Thrombus","author":"Lamichhane","year":"2018"},{"key":"2026081717102365300_cit2","doi-asserted-by":"publisher","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism:\na public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am. J. Prev. Med."},{"key":"2026081717102365300_cit3","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of\nthrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ. Res."},{"key":"2026081717102365300_cit4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1517\/13543776.2016.1154045","article-title":"Factor XIa inhibitors:\nA review of the patent literature","volume":"26","author":"Al-Horani","year":"2016","journal-title":"Expert Opin.\nTher. Pat."},{"key":"2026081717102365300_cit5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1021\/acs.jmedchem.9b01060","article-title":"Fibrinolysis\ninhibitors: potential drugs for the treatment and prevention of bleeding","volume":"63","author":"Steinmetzer","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026081717102365300_cit6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/pgmj.2007.059188","article-title":"Heparin induced thrombocytopenia:\ndiagnosis and management update","volume":"83","author":"Ahmed","year":"2007","journal-title":"Postgrad. Med.\nJ."},{"key":"2026081717102365300_cit7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5694\/j.1326-5377.2002.tb04807.x","article-title":"Low molecular weight\nheparins and heparinoids","volume":"177","author":"Eikelboom","year":"2002","journal-title":"Med. J. Aust."},{"key":"2026081717102365300_cit8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4236\/wjns.2012.21002","article-title":"Clinical and pharmacological\nproperties of new oral anticoagulants\nfor the prevention of cerebral thromboembolism: Factor Xa and thrombin\ninhibitors","volume":"02","author":"Winter","year":"2012","journal-title":"World J. Neurosci."},{"key":"2026081717102365300_cit9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial\nfibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2026081717102365300_cit10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the\nefficacy and safety of new oral anticoagulants with warfarin in patients\nwith atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2026081717102365300_cit11","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00392-017-1098-x","article-title":"Comparative\nrisk of major bleeding\nwith new oral anticoagulants (NOACs) and phenprocoumon in patients\nwith atrial fibrillation: a post-marketing surveillance study","volume":"106","author":"Hohnloser","year":"2017","journal-title":"Clin. Res. Cardiol."},{"key":"2026081717102365300_cit12","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1021\/acschembio.5b00103","article-title":"A synthetic factor XIIa inhibitor\nblocks selectively intrinsic coagulation initiation","volume":"10","author":"Baeriswyl","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"2026081717102365300_cit13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1055\/s-0036-1598003","article-title":"Factor XII\ncontact activation","volume":"43","author":"Naudin","year":"2017","journal-title":"Semin. Thromb. Hemostasis"},{"key":"2026081717102365300_cit14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective\nthrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renne","year":"2005","journal-title":"J. Exp. Med."},{"key":"2026081717102365300_cit15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.drudis.2014.06.024","article-title":"Factor XII: a drug\ntarget for safe interference with thrombosis and\ninflammation","volume":"19","author":"Kenne","year":"2014","journal-title":"Drug Discovery Today"},{"key":"2026081717102365300_cit16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/joim.12430","article-title":"Factor XII:\na novel target for safe\nprevention of thrombosis and inflammation","volume":"278","author":"Kenne","year":"2015","journal-title":"J.\nIntern. Med."},{"key":"2026081717102365300_cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112753","article-title":"Factor XII\/XIIa inhibitors:\ntheir discovery, development, and potential indications","volume":"208","author":"Davoine","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"2026081717102365300_cit18","doi-asserted-by":"publisher","first-page":"060","DOI":"10.1055\/s-0037-1603937","article-title":"Inhibition of factors\nXI and XII for prevention of\nthrombosis induced by artificial surfaces","volume":"44","author":"Tillman","year":"2018","journal-title":"Semin.\nThromb. Hemostasis"},{"key":"2026081717102365300_cit19","doi-asserted-by":"publisher","first-page":"222ra17","DOI":"10.1126\/scitranslmed.3006804","article-title":"A factor XIIa\ninhibitory antibody provides thromboprotection in extracorporeal circulation\nwithout increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci. Transl.\nMed."},{"key":"2026081717102365300_cit20","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","article-title":"Selective\ndepletion of factor XI\nor factor XII with antisense oligonucleotides attenuates catheter\nthrombosis in rabbits","volume":"123","author":"Yau","year":"2014","journal-title":"Blood"},{"key":"2026081717102365300_cit21","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1016\/j.actbio.2012.07.019","article-title":"Corn trypsin inhibitor\ncoating attenuates the prothrombotic properties of catheters in vitro\nand in vivo","volume":"8","author":"Yau","year":"2012","journal-title":"Acta Biomater."},{"key":"2026081717102365300_cit22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/jth.12500","article-title":"Dabigatran\nversus warfarin in patients\nwith mechanical heart valves: reply","volume":"12","author":"Eikelboom","year":"2014","journal-title":"J. Thromb.\nHaemostasis"},{"key":"2026081717102365300_cit23","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1182\/blood-2011-07-364141","article-title":"Mechanism of catheter thrombosis:\ncomparison of the antithrombotic activities of fondaparinux, enoxaparin,\nand heparin in vitro and in vivo","volume":"118","author":"Yau","year":"2011","journal-title":"Blood"},{"key":"2026081717102365300_cit24","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI77139","article-title":"Defective glycosylation\nof coagulation\nfactor XII underlies hereditary angioedema type III","volume":"125","author":"Bjo\u0308rkqvist","year":"2015","journal-title":"J. Clin. Invest."},{"key":"2026081717102365300_cit25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/rth2.12217","article-title":"The contact\npathway and sepsis","volume":"3","author":"Raghunathan","year":"2019","journal-title":"Res. Pract. Thromb. Haemostasis"},{"key":"2026081717102365300_cit26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11626","article-title":"Blood coagulation factor XII drives adaptive immunity\nduring neuroinflammation via CD87-mediated modulation of dendritic\ncells","volume":"7","author":"Go\u0308bel","year":"2016","journal-title":"Nat. Commun."},{"key":"2026081717102365300_cit27","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1182\/blood-2016-11-753202","article-title":"Depletion of coagulation factor XII ameliorates brain\npathology and cognitive impairment in Alzheimer disease mice","volume":"129","author":"Chen","year":"2017","journal-title":"Blood"},{"key":"2026081717102365300_cit28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1182\/bloodadvances.2018016337","article-title":"Structures\nof human plasma beta-factor\nXIIa cocrystallized with potent inhibitors","volume":"2","author":"Dementiev","year":"2018","journal-title":"Blood Adv."},{"key":"2026081717102365300_cit29","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1016\/S0006-3495(96)79479-1","article-title":"Crystal structures of thrombin with\nthiazole-containing\ninhibitors: probes of the S1\u2019 binding site","volume":"71","author":"Matthews","year":"1996","journal-title":"Biophys. J."},{"key":"2026081717102365300_cit30","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.21037\/cdt.2017.11.02","article-title":"Thrombosis\nin cancer patients: etiology,\nincidence, and management","volume":"7","author":"Sheth","year":"2017","journal-title":"Cardiovasc. Diagn.\nTher."},{"key":"2026081717102365300_cit31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of\ninitial\nand recurrent thromboembolic disease among patients with malignancy\nversus those without malignancy. Risk analysis using Medicare claims\ndata","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine"},{"key":"2026081717102365300_cit32","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-014-0054-8","article-title":"Tissue factor in tumor microenvironment:\na systematic review","volume":"7","author":"Han","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"2026081717102365300_cit33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1160\/TH17-08-0596","article-title":"Contact\nsystem activation and cancer: new insights in the pathophysiology\nof cancer-associated thrombosis","volume":"118","author":"Campello","year":"2018","journal-title":"Thromb. Haemostasis"},{"key":"2026081717102365300_cit34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1160\/TH13-10-0812","article-title":"New players in haemostasis and thrombosis","volume":"111","author":"Geddings","year":"2014","journal-title":"Thromb. Haemostasis"},{"key":"2026081717102365300_cit35","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/jth.12295","article-title":"Factor\nXII promotes blood coagulation independent of factor XI in the presence\nof long-chain polyphosphates","volume":"11","author":"Puy","year":"2013","journal-title":"J. Thromb. Haemostasis"},{"key":"2026081717102365300_cit36","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1111\/j.1538-7836.2011.04465.x","article-title":"Breast cancer chemotherapy induces\nthe release of cell-free DNA, a novel procoagulant stimulus","volume":"9","author":"Swystun","year":"2011","journal-title":"J. Thromb. Haemostasis"},{"key":"2026081717102365300_cit37","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3892\/ijo.2017.4172","article-title":"Differential contribution of tissue factor and Factor\nXII to thrombin generation triggered by breast and pancreatic cancer\ncells","volume":"51","author":"Rousseau","year":"2017","journal-title":"Int. J. Oncol."},{"key":"2026081717102365300_cit38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/blood-2015-01-622811","article-title":"The polyphosphate-factor\nXII pathway drives coagulation in prostate cancer-associated thrombosis","volume":"126","author":"Nickel","year":"2015","journal-title":"Blood"},{"key":"2026081717102365300_cit39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3978\/j.issn.2305-5839.2015.09.07","article-title":"The factor\nXIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory\nactivities","volume":"3","author":"Worm","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"2026081717102365300_cit40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1107\/S0907444912009067","article-title":"The kazal-type\ninhibitors infestins\n1 and 4 differ in specificity but are similar in three-dimensional\nstructure","volume":"68","author":"Campos","year":"2012","journal-title":"Acta Crystallogr., Sect. D: Biol.\nCrystallogr."},{"key":"2026081717102365300_cit41","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1021\/acs.jmedchem.6b01548","article-title":"Peptide macrocycle\ninhibitor of coagulation\nfactor XII with subnanomolar affinity and high target selectivity","volume":"60","author":"Middendorp","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026081717102365300_cit42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejmech.2016.01.023","article-title":"Synthesis, evaluation\nand structure-activity relationship of new 3-carboxamide coumarins\nas FXIIa inhibitors","volume":"110","author":"Bouckaert","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"2026081717102365300_cit43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejmech.2017.08.056","article-title":"Identifying novel factor XIIa inhibitors\nwith PCA-GA-SVM developed vHTS models","volume":"140","author":"Chen","year":"2017","journal-title":"Eur.\nJ. Med. Chem."},{"key":"2026081717102365300_cit44","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1134\/S1070427211110097","article-title":"Synthesis\nof 3-pyridyl-substituted 5-amino-1,2,4-triazoles from aminoguanidine\nand pyridinecarboxylic acids","volume":"84","author":"Chernyshev","year":"2011","journal-title":"Russ. J. Appl.\nChem."},{"key":"2026081717102365300_cit45","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/j.tetlet.2009.02.172","article-title":"An aqueous medium\nsynthesis and tautomerism study of 3(5)-amino-1,2,4-triazoles","volume":"50","author":"Dolzhenko","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"2026081717102365300_cit46","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3987\/COM-12-12542","article-title":"Synthesis of novel trichloromethyl\nsubstituted azolo\u00ad[1,3,5]\u00adtriazines","volume":"85","author":"Dolzhenko","year":"2012","journal-title":"Heterocycles"},{"key":"2026081717102365300_cit47","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1021\/jm5008193","article-title":"Synthesis,\nantimitotic and antivascular activity of 1-(3\u2019,4\u2019,5\u2019-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles","volume":"57","author":"Romagnoli","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026081717102365300_cit48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejmech.2013.06.051","article-title":"A structure-activity\nrelationship\nstudy of 1,2,4-triazolo\u00ad[1,5-a]\u00ad[1,3,5]\u00adtriazin-5,7-dione and its 5-thioxo\nanalogues on anti-thymidine phosphorylase and associated anti-angiogenic\nactivities","volume":"67","author":"Bera","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"2026081717102365300_cit49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201377","article-title":"Reversible covalent\ndirect thrombin\ninhibitors","volume":"13","author":"Sivaraja","year":"2018","journal-title":"PLoS One"},{"key":"2026081717102365300_cit50","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1021\/acs.jmedchem.7b00772","article-title":"Design\nof small-molecule active-site inhibitors of the S1A family proteases\nas procoagulant and anticoagulant drugs","volume":"61","author":"Fischer","year":"2018","journal-title":"J.\nMed. Chem."},{"key":"2026081717102365300_cit51","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/ATVBAHA.118.311193","article-title":"Factor XII activation promotes platelet\nconsumption\nin the presence of bacterial-type long-chain polyphosphate In vitro\nand in vivo","volume":"38","author":"Zilberman-Rudenko","year":"2018","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"2026081717102365300_cit52","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.258.258","volume-title":"Stimulated Platelets\nbut not Endothelium Generate Thrombin via a Factor XIIa-dependent\nMechanism Requiring Phosphatidylserine Exposure","author":"Bendapudi","year":"2016"},{"key":"2026081717102365300_cit53","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20130057","article-title":"Activation of blood coagulation in cancer: implications\nfor tumour progression","volume":"33","author":"Lima","year":"2013","journal-title":"Biosci. Rep."},{"key":"2026081717102365300_cit54","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.3390\/molecules23112753","article-title":"The low molecular weight heparin tinzaparin attenuates\nplatelet activation in terms of metastatic niche formation by coagulation-dependent\nand independent pathways","volume":"23","author":"Gockel","year":"2018","journal-title":"Molecules"},{"key":"2026081717102365300_cit55","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.96.20.11023","article-title":"How the\nprotease thrombin talks to cells","volume":"96","author":"Coughlin","year":"1999","journal-title":"Proc. Natl.\nAcad. Sci. U.S.A."},{"key":"2026081717102365300_cit56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1124\/mol.116.106666","article-title":"Contributions\nof protease-activated\nreceptors PAR1 and PAR4 to thrombin-induced GPIIbIIIa activation in\nhuman platelets","volume":"91","author":"Duvernay","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"2026081717102365300_cit57","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1016\/S0021-9258(18)42664-6","article-title":"Structure-function relationships in the activation\nof platelet thrombin receptors by receptor-derived peptides","volume":"267","author":"Vassallo","year":"1992","journal-title":"J. Biol. Chem."},{"key":"2026081717102365300_cit58","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.thromres.2015.06.034","article-title":"Paradoxical enhancement of the intrinsic pathway-induced\nthrombin generation in human plasma by melagatran, a direct thrombin\ninhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin","volume":"136","author":"Furugohri","year":"2015","journal-title":"Thromb. Res."},{"key":"2026081717102365300_cit59","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/jth.12591","article-title":"Direct thrombin inhibitors,\nbut not the direct factor Xa inhibitor rivaroxaban, increase tissue\nfactor-induced hypercoagulability in vitro and in vivo","volume":"12","author":"Perzborn","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"2026081717102365300_cit60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.thromres.2016.03.005","article-title":"A direct thrombin inhibitor suppresses\nprotein C activation and factor Va degradation in human plasma: Possible\nmechanisms of paradoxical enhancement of thrombin generation","volume":"141","author":"Kamisato","year":"2016","journal-title":"Thromb. Res."},{"key":"2026081717102365300_cit61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function\nof fatty acid amide hydrolase","volume":"74","author":"McKinney","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"2026081717102365300_cit62","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2174\/092986710791859414","article-title":"A review\non the monoacylglycerol\nlipase: at the interface between fat and endocannabinoid signalling","volume":"17","author":"Labar","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"2026081717102365300_cit63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade\nof anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"2026081717102365300_cit64","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/cbic.200800428","article-title":"CAY10499, a novel monoglyceride lipase\ninhibitor evidenced by an expeditious MGL assay","volume":"9","author":"Muccioli","year":"2008","journal-title":"ChemBiochem"},{"key":"2026081717102365300_cit65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT\n- integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr., Sect. A: Found. Adv."},{"key":"2026081717102365300_cit66","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1021\/acs.jmedchem.6b00606","article-title":"Optimization\nof cyclic plasmin inhibitors: from benzamidines to benzylamines","volume":"59","author":"Hinkes","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026081717102365300_cit67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/BJ20130101","article-title":"Identification of the first synthetic\ninhibitors of the type II transmembrane serine protease TMPRSS2 suitable\nfor inhibition of influenza virus activation","volume":"452","author":"Meyer","year":"2013","journal-title":"Biochem. J."},{"key":"2026081717102365300_cit68","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.bpj.2012.10.011","article-title":"Thrombin\nactivity propagates in space during blood\ncoagulation as an excitation wave","volume":"103","author":"Dashkevich","year":"2012","journal-title":"Biophys.\nJ."},{"key":"2026081717102365300_cit69","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.bpj.2018.11.009","article-title":"Sensitivity\nand robustness of spatially dependent thrombin generation and fibrin\nclot propagation","volume":"115","author":"Kuprash","year":"2018","journal-title":"Biophys. J."},{"key":"2026081717102365300_cit70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12550-009-0006-2","article-title":"Large-scale\nproduction of selected\ntype A trichothecenes: the use of HT-2 toxin and T-2 triol as precursors\nfor the synthesis of d 3-T-2 and d 3-HT-2 toxin","volume":"25","author":"Beyer","year":"2009","journal-title":"Mycotoxin Res."},{"key":"2026081717102365300_cit71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0022-1759(98)00028-3","article-title":"A novel one-step, highly\nsensitive fluorometric assay to evaluate cell-mediated cytotoxicity","volume":"213","author":"Nociari","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"2026081717102365300_cit72","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1021\/acs.jnatprod.8b00187","article-title":"Auranthine,\na benzodiazepinone from\npenicillium aurantiogriseum: refined structure, absolute configuration,\nand cytotoxicity","volume":"81","author":"Kalinina","year":"2018","journal-title":"J. Nat. Prod."},{"key":"2026081717102365300_cit73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejmech.2013.01.050","article-title":"(4-Phenoxyphenyl)\u00adtetrazolecarboxamides\nand related compounds as dual inhibitors of fatty acid amide hydrolase\n(FAAH) and monoacylglycerol lipase (MAGL)","volume":"63","author":"Holtfrerich","year":"2013","journal-title":"Eur.\nJ. Med. Chem."},{"key":"2026081717102365300_cit74","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/cmdc.201500445","article-title":"omega-Imidazolyl- and\nomega-tetrazolylalkylcarbamates as inhibitors\nof fatty acid amide hydrolase: biological activity and in vitro metabolic\nstability","volume":"11","author":"Terwege","year":"2016","journal-title":"ChemMedChem"},{"key":"2026081717102365300_cit75","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00216-009-2850-5","article-title":"High-performance liquid chromatographic\nassay with fluorescence detection for the evaluation of inhibitors\nagainst fatty acid amide hydrolase","volume":"394","author":"Forster","year":"2009","journal-title":"Anal. Bioanal.\nChem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.0c01635","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/21\/13159\/13398894\/jm0c01635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/21\/13159\/13398894\/jm0c01635.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:42Z","timestamp":1787003022000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/63\/21\/13159\/501575\/Acylated-1H-1-2-4-Triazol-5-amines-Targeting-Human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":75,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,10,22]]},"published-print":{"date-parts":[[2020,11,12]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01635","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01635.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01635.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01635.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01635.s004","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]}}}